Crystal structure of HIV-1 reverse transcriptase bound to a non-nucleoside inhibitor with a novel mechanism of action.

作者信息

Freisz Séverine, Bec Guillaume, Radi Marco, Wolff Philippe, Crespan Emmanuele, Angeli Lucilla, Dumas Philippe, Maga Giovanni, Botta Maurizio, Ennifar Eric

机构信息

Architecture et réactivité de l'ARN, Université de Strasbourg, CNRS, Institut de Biologie Moléculaire et Cellulaire, 15 rue René Descartes, 67084 Strasbourg, France.

出版信息

Angew Chem Int Ed Engl. 2010 Mar 1;49(10):1805-8. doi: 10.1002/anie.200905651.

DOI:10.1002/anie.200905651

PMID:20135654

Abstract

摘要

相似文献

Crystal structure of HIV-1 reverse transcriptase bound to a non-nucleoside inhibitor with a novel mechanism of action.

Angew Chem Int Ed Engl. 2010 Mar 1;49(10):1805-8. doi: 10.1002/anie.200905651.

Unconventional plasticity of HIV-1 reverse transcriptase: how inhibitors could open a connection "gate" between allosteric and catalytic sites.

J Chem Inf Model. 2013 Dec 23;53(12):3117-22. doi: 10.1021/ci400414s. Epub 2013 Nov 25.

Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.

Bioorg Med Chem. 2004 Dec 1;12(23):6085-95. doi: 10.1016/j.bmc.2004.09.008.

Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

J Med Chem. 2007 Apr 19;50(8):1778-86. doi: 10.1021/jm061167r. Epub 2007 Mar 24.

Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.

J Med Chem. 2004 Nov 18;47(24):5912-22. doi: 10.1021/jm040071z.

Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.

J Med Chem. 2005 May 5;48(9):3433-7. doi: 10.1021/jm049279a.

Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.

J Med Chem. 2007 Dec 27;50(26):6580-95. doi: 10.1021/jm0708230. Epub 2007 Dec 6.

Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.

J Med Chem. 2005 Dec 1;48(24):7582-91. doi: 10.1021/jm0500323.

Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.

J Med Chem. 2012 Apr 26;55(8):3595-613. doi: 10.1021/jm200990c. Epub 2012 Feb 15.

N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Bioorg Med Chem Lett. 2010 Mar 1;20(5):1585-8. doi: 10.1016/j.bmcl.2010.01.086. Epub 2010 Jan 21.

引用本文的文献

Halo Library, a Tool for Rapid Identification of Ligand Binding Sites on Proteins Using Crystallographic Fragment Screening.

J Med Chem. 2023 May 11;66(9):6013-6024. doi: 10.1021/acs.jmedchem.2c01681. Epub 2023 Apr 28.

Human endogenous retrovirus-K (HERV-K) reverse transcriptase (RT) structure and biochemistry reveals remarkable similarities to HIV-1 RT and opportunities for HERV-K-specific inhibition.

Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2200260119. doi: 10.1073/pnas.2200260119. Epub 2022 Jun 30.

Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance.

Curr Opin Struct Biol. 2020 Apr;61:113-123. doi: 10.1016/j.sbi.2019.11.011. Epub 2020 Jan 11.

Structural Basis of HIV-1 Inhibition by Nucleotide-Competing Reverse Transcriptase Inhibitor INDOPY-1.

J Med Chem. 2019 Nov 14;62(21):9996-10002. doi: 10.1021/acs.jmedchem.9b01289. Epub 2019 Oct 25.

Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase.

Acta Crystallogr F Struct Biol Commun. 2015 Nov;71(Pt 11):1384-90. doi: 10.1107/S2053230X15017896. Epub 2015 Oct 23.

Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening.

Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6979-84. doi: 10.1073/pnas.1423900112. Epub 2015 May 18.

Derivatives of mesoxalic acid block translocation of HIV-1 reverse transcriptase.

J Biol Chem. 2015 Jan 16;290(3):1474-84. doi: 10.1074/jbc.M114.614305. Epub 2014 Oct 29.

Protein-mediated antagonism between HIV reverse transcriptase ligands nevirapine and MgATP.

Biophys J. 2013 Jun 18;104(12):2695-705. doi: 10.1016/j.bpj.2013.04.015.

Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series.

Antimicrob Agents Chemother. 2013 Jun;57(6):2712-8. doi: 10.1128/AAC.00113-13. Epub 2013 Apr 1.

HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions.

Mol Biol Int. 2012;2012:586401. doi: 10.1155/2012/586401. Epub 2012 Jun 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验